Fosigotifator
AssetAlso ABBV-CLS-7262, FOSIGOTIFATOR SODIUM TROMETHAMINE
Activates eIF2B to decrease the integrated stress response.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Proteostasis
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Vanishing white matter disease
Phase 2, calicolabs.com, 10 Oct 2026
ALS
Phase 1, calicolabs.com, 7 Oct 2026
In the full profile
- Targets and what it contains6
- Owner and partners2
- Trials1
- Evidence for its targets3
- Competitors8
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.